EBACHATamoxicillinclarithromycinHelicobacter pyloritegoprazanesomeprazoleH. pylori
…BAC in the intention-to-treat analysis. HAT was non-inferior to EBAC (risk difference -1.9%, 95% CI -9.3 to 5.5), while LAT was not …
Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…BAC in the intention-to-treat analysis. HAT was non-inferior to EBAC (risk difference -1.9%, 95% CI -9.3 to 5.5), while LAT was not …